© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Lynn J. Howie, MD, MA
Articles
A Comparison of FDA and EMA Drug Approval: Implications for Drug Development and Cost of Care
December 15, 2013
The development and approval of oncology therapeutics has been facilitated by the cooperation and coordination of regulatory practices between the EMA and the FDA. However, there continue to be important differences between the decisions of the two agencies.